Healthcare
Live Price
Offline$0.007
+0.00% today
1Y Change
-90.27%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Yubo International Biotech Limited (YBGJ) is a Healthcare stock with listed on OTC. The stock last traded around $0.01 and down 90.3% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +3772.9%, EPS growth of +32.4%, a dividend yield of 0.0%. What stands out right now is revenue +3772.9%, EPS +32.4%, free cash flow +37.0% with operating margin -883.8% and ROIC 57.8%. Valuation sits in the middle of the pack at price/sales 7.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YBGJ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YBGJ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YBGJ Max Drawdown
-94.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YBGJ and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for YBGJ
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.